Erik Walum

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Investigation of the Effects of a Novel NOX2 Inhibitor, GLX7013170, against Glutamate Excitotoxicity and Diabetes Insults in the Retina.

Investigation of the Effects of a Novel NOX2 Inhibitor, GLX7013170, against Glutamate Excitotoxicity and Diabetes Insults in the Retina.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: February 09, 2024

Topically Administered NOX4 Inhibitor, GLX7013114, Is Efficacious in Treating the Early Pathological Events of Diabetic Retinopathy.

Topically Administered NOX4 Inhibitor, GLX7013114, Is Efficacious in Treating the Early Pathological Events of Diabetic Retinopathy.

Journal: Diabetes

Published: June 06, 2022

A small molecule inhibitor of Nox2 and Nox4 improves contractile function after ischemia-reperfusion in the mouse heart.

A small molecule inhibitor of Nox2 and Nox4 improves contractile function after ischemia-reperfusion in the mouse heart.

Journal: Scientific reports

Published: March 05, 2021

Effect of NADPH oxidase inhibitors in an experimental retinal model of excitotoxicity.

Effect of NADPH oxidase inhibitors in an experimental retinal model of excitotoxicity.

Journal: Experimental eye research

Published: May 09, 2020

A novel NADPH oxidase inhibitor targeting Nox4 in TGFβ-induced lens epithelial to mesenchymal transition.

A novel NADPH oxidase inhibitor targeting Nox4 in TGFβ-induced lens epithelial to mesenchymal transition.

Journal: Experimental eye research

Published: March 11, 2019

The novel NADPH oxidase 4 selective inhibitor GLX7013114 counteracts human islet cell death in vitro.

The novel NADPH oxidase 4 selective inhibitor GLX7013114 counteracts human islet cell death in vitro.

Journal: PloS one

Published: May 31, 2018

The novel NADPH oxidase 4 inhibitor GLX351322 counteracts glucose intolerance in high-fat diet-treated C57BL/6 mice.

The novel NADPH oxidase 4 inhibitor GLX351322 counteracts glucose intolerance in high-fat diet-treated C57BL/6 mice.

Journal: Free radical research

Published: June 30, 2015

Scandinavian Society for Cell Toxicology--thirty years of scientific pioneering.

Scandinavian Society for Cell Toxicology--thirty years of scientific pioneering.

Journal: Basic & clinical pharmacology & toxicology

Published: September 23, 2013

Showing 1-8 of 8

Last Updated: 09/26/2026